Asmanex twisthaler and Ultracet drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Asmanex twisthaler and Ultracet. Common interactions include anhedonia among females.

The phase IV clinical study analyzes what interactions people who take Asmanex twisthaler and Ultracet have. It is created by eHealthMe based on reports of 19 people who take Asmanex twisthaler and Ultracet from the FDA, and is updated regularly. You can use the study as a second opinion to make health care decisions.

Phase IV trials are used to detect adverse drug outcomes and monitor drug effectiveness in the real world. With medical big data and AI algorithms, eHealthMe is running millions of phase IV trials and makes the results available to the public. Our original studies have been referenced on 600+ medical publications including The Lancet, Mayo Clinic Proceedings, and Nature.



On Oct, 19, 2022

19 people who take Asmanex twisthaler and Ultracet together, and have interactions are studied.


What is Asmanex twisthaler?

Asmanex twisthaler has active ingredients of mometasone furoate. It is often used in asthma. eHealthMe is studying from 3,121 Asmanex twisthaler users for its effectiveness, alternative drugs and more.

What is Ultracet?

Ultracet has active ingredients of acetaminophen; tramadol hydrochloride. It is often used in pain. eHealthMe is studying from 5,994 Ultracet users for its effectiveness, alternative drugs and more.

Number of Asmanex twisthaler and Ultracet reports submitted per year:

Asmanex twisthaler and Ultracet drug interactions.

Common Asmanex Twisthaler and Ultracet drug interactions by gender *:

female:

  1. Anhedonia
  2. Anxiety
  3. Hot flush
  4. Hydronephrosis
  5. Injury
  6. Kyphosis
  7. Metastases to bone
  8. Osteoarthritis
  9. Osteonecrosis of jaw
  10. Pelvi-ureteric obstruction

male:

n/a

Common Asmanex Twisthaler and Ultracet drug interactions by age *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

n/a

30-39:

  1. Akathisia
  2. Dyskinesia
  3. Formication
  4. Tardive dyskinesia

40-49:

n/a

50-59:

n/a

60+:

  1. Asthenia
  2. Constipation
  3. Dizziness
  4. Dyspnoea
  5. Erythema
  6. Fatigue
  7. Feeling hot
  8. Hyperhidrosis
  9. Hypothyroidism
  10. Pruritus

Common conditions people have *:

  1. Muscle Spasms (muscle contraction): 15 people, 78.95%
  2. Metastases To Bone (cancer spreads to bone): 15 people, 78.95%
  3. Constipation: 15 people, 78.95%
  4. Breast Cancer Metastatic: 15 people, 78.95%
  5. Breast Cancer: 15 people, 78.95%
  6. Wheezing (a high-pitched whistling sound made while you breath): 1 person, 5.26%
  7. Pulmonary Hypertension (increase in blood pressure in the lung artery): 1 person, 5.26%
  8. Low Density Lipoprotein Increased (cholesterol increased in blood): 1 person, 5.26%
  9. High Density Lipoprotein Decreased: 1 person, 5.26%
  10. Gastroesophageal Reflux Disease (a condition in which stomach contents leak backward from the stomach into the oesophagus): 1 person, 5.26%

* Approximation only. Some reports may have incomplete information.

Do you take Asmanex twisthaler and Ultracet?

Personalize this study to your gender and age

How to use the study?

You can discuss the study with your doctor, to ensure that all drug risks and benefits are fully discussed and understood.



Related studies

Alternative drugs to, pros and cons of the 2 drugs:

Browse all drug interactions of Asmanex twisthaler and Ultracet:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Common Asmanex twisthaler interactions:

Browse all interactions between Asmanex twisthaler and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Common Ultracet interactions:

Browse all interactions between Ultracet and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

How the study uses the data?

The study uses data from the FDA. It is based on mometasone furoate and acetaminophen; tramadol hydrochloride (the active ingredients of Asmanex twisthaler and Ultracet, respectively), and Asmanex twisthaler and Ultracet (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study. Patients in the study may take other drugs besides Asmanex twisthaler and Ultracet.

Who is eHealthMe?

With medical big data and proven AI algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 600+ medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.

Recent studies on eHealthMe: